Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma

NCT00730444 · clinicaltrials.gov ↗

APPROVED_FOR_MARKETING

Status

INDUSTRY

Sponsor class

Conditions

Neuroblastoma

Interventions

DRUG: Iobenguane I 123 Injection

Sponsor

GE Healthcare